ORTHOPEDIATRICS CORP 8-K

What Happened

• On January 12, 2026, OrthoPediatrics Corp. announced preliminary, unaudited net revenue and free cash flow results for the quarter and full year ended December 31, 2025, and provided management’s projection for 2026 net revenue. The company furnished a press release with these details as Exhibit 99.1 to its Form 8-K.

Key Details

• Filing date: January 12, 2026 (Form 8-K).
• Period covered: fourth quarter and full year ended December 31, 2025 (preliminary, unaudited results).
• Company provided a management projection of net revenue for 2026.
• The related press release was included as Exhibit 99.1 and the Form 8-K was signed by Daniel J. Gerritzen, General Counsel and Secretary.

Why It Matters

• Investors get an early look at OrthoPediatrics’ revenue and free cash flow trends for Q4 and full-year 2025 and a first indication of management’s revenue expectations for 2026.
• Because the figures are described as preliminary and unaudited, they may be adjusted when final audited results are released; however, the update can affect near-term investor and analyst expectations for earnings, revenue guidance, and cash-flow outlook.
• The press release as an exhibit makes the details available for review and for incorporation into analyst models or investor decision-making.